Navigation Links
Actavis First Quarter 2013 Net Revenue Increases 24% to $1.9 Billion
Date:5/2/2013

ding generic Singulair® in multiple European markets and the successful patent challenge of generic Crestor® in Australia."

"In our Actavis Specialty Brands business, we experienced growth from U.S. sales of key promoted products including Generess® Fe, Rapaflo®,  Crinone® and Androderm®. We also continued to build our Specialty Brands pipeline for future growth.  In January, we acquired Uteron Pharma SA which significantly enhanced our Specialty Brands development portfolio in Women's Health worldwide. In February, we filed our progestin-only patch contraceptive product with the FDA ahead of schedule.  In April, we announced a strategic agreement with Valeant that will maximize the commercial value of Actavis' Cordran® Tape and Valeant's Zovirax® cream 5% through co-promotion agreements and earlier this week we licensed in Metronidazole 1.3% Vaginal Gel, capitalizing on the commercial reach of our specialty brand sales force," Bisaro continued.

"As a result of the strong performance of our global businesses during the first quarter, we are now increasing our forecast for 2013 Non-GAAP earnings per diluted share in the range of $8.10 - $8.50, representing growth of 35 to 42 percent over 2012," concluded Bisaro. 

First Quarter 2013 Business Segment Results  Actavis Pharma Segment InformationThree Months EndedMarch 31,(Unaudited; $ in millions)20132012Product sales

$
,524.1$
,108.0Other revenue

9.78.1Net revenue

1,533.81,116.1Operating expenses:Cost of sales

861.9614.2Research and development

98.856.1Selling and marketing

159.347.5Segment contribution

$
413.8$
398.3Segment margin

27.0%35.7%Adjusted gross profit (1)

$
782.5$
503.6Adjusted gross margin

50.7%45.1%(1)Adjusted gross profit
'/>"/>

SOURCE Actavis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Actavis Acquires Worldwide Rights for Valeants Metronidazole 1.3% Vaginal Gel
2. Actavis, Inc. to Host First Quarter 2013 Earnings Conference Call and Webcast
3. Former Clinton Deputy Solicitor General sheds light on flaws in Federal Trade Commissions case in FTC v. Actavis Inc.
4. Actavis, Inc. to Present at the Barclays 2013 Global Healthcare Conference
5. Actavis, Inc. to Present at the Cowen & Company 33rd Annual Health Care Conference
6. Actavis Full Year 2012 Net Revenue Increases 29% to $5.91 Billion
7. Actavis, Inc. to Present at the RBC Capital Markets Healthcare Conference
8. Actavis, Inc. to Host Fourth Quarter 2012 Earnings Conference Call and Webcast
9. Watson Pharmaceuticals, Inc. is Now Actavis, Inc.
10. Watson Announces New Name -- Actavis -- for Global Operations
11. Watson and Actavis Receive FTC Second Request
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/2/2015)... , Aug. 3, 2015  Lexicon Pharmaceuticals, Inc. ... pivotal TELESTAR Phase 3 clinical trial met its ... etiprate in treating cancer patients with carcinoid syndrome ... standard of care. Telotristat etiprate was discovered using ... and is the company,s first discovery to complete ...
(Date:7/31/2015)... , July 31, 2015  Seeger Weiss LLP is ... (FDA) issued a warning letter to C.R. Bard, the manufacturer ... taking adequate strides to correct violations the agency found at ... these violations after the FDA cited them during Inspectional Observations ... in Bard,s Tempe, AZ , location and ...
(Date:7/31/2015)... July 31, 2015 RnRMarketResearch.com ... market research report that provides an overview of ... data sourced from in-house databases, secondary and primary ... needles market products pipeline spread across 124 pages, ... 73 tables and 5 figures is now available ...
Breaking Medicine Technology:Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 2Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 3Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 4Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 5Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 6Seeger Weiss LLP Reports That The FDA Has Issued A Warning Letter To IVC Filter Manufacturer, C.R. Bard 2Seeger Weiss LLP Reports That The FDA Has Issued A Warning Letter To IVC Filter Manufacturer, C.R. Bard 3Syringes and Needles Market Products Pipeline Review 2015 Report 2Syringes and Needles Market Products Pipeline Review 2015 Report 3Syringes and Needles Market Products Pipeline Review 2015 Report 4Syringes and Needles Market Products Pipeline Review 2015 Report 5
(Date:8/3/2015)... , ... August 03, 2015 , ... ... brokerage firm, announced today that Joe Williams has joined its growing California employee ... delivering HUB's differentiated service model to his clients. Mr. Williams will be joining ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... management and investigative services, has introduced a new logo and comprehensive brand ... that improve business outcomes for its customers. EMSI’s new tagline, “Powerful Information. ...
(Date:8/2/2015)... ... 03, 2015 , ... Career Step, an online institution offering ... for Healthcare Documentation Integrity’s (AHDI) conference being held in Alexandria, Virginia, on Friday ... AHDI conference provides us to interact with those in the healthcare documentation industry,” ...
(Date:8/2/2015)... (PRWEB) , ... August 02, 2015 , ... Molecular biologists ... powerful prognostic indicator for mesothelioma. Surviving Mesothelioma has just posted an article on the ... University of New South Wales tested for Ki67 expression in tissue samples from 42 ...
(Date:8/1/2015)... ... 2015 , ... Have you ever wondered what “Karma” really means? Does it even exist? Can ... , Vedic tradition, which gave birth to Hinduism, is one of the most ancient spiritual ... this tradition. According to the wisdom of this heritage, Karma is a very real and ...
Breaking Medicine News(10 mins):Health News:HUB International Insurance Services Announces Joe Williams Has Joined its Northern California Employee Benefits Division 2Health News:EMSI Announces New Branding: Powerful Information. Improved Outcomes. 2Health News:Career Step to Exhibit at AHDI Conference in Alexandria, Virginia on August 7-8 2Health News:Scientists Link Protein Marker with Mesothelioma Prognosis in New Study, According to Surviving Mesothelioma 2Health News:Nithyananda Yoga Foundation to Conduct Global Webinar on Karma at No Charge on August 1st 2
... ... with Alzheimer,s disease and disabilities, and a decreasing work force to care for them, threatens ... care business owner. , ... NE (PRWEB) September 29, 2009 -- A crisis in aging, fueled by increasing numbers of ...
... ... foot and ankle Pain." Claims Dr. Katz , ... Tampa, FL (PRWEB) September 29, 2009 -- Foot pain and foot ... of solutions for their foot and ankle pain and are growing frustrated with continuous visits ...
... study by researchers at The George Institute for International Health ... to PCPs with acute lower back pain to have previously ... documented was vertebral fracture, with half of the cases identified ... in the October issue of Arthritis & Rheumatism , ...
... shoe choices early in life suffer with foot pain in later ... foot pain as women, due to type of shoes they wear. ... Arthritis Care & Research , a journal published by Wiley-Blackwell ... reveal that foot and toe symptoms are among the top 20 ...
... cancer with the Prostate Specific Antigen (PSA) test in ... becomes symptomatic, knowing whether screening is beneficial for these ... or no reductions in prostate cancer mortality among those ... against the more common and immediate downsides of increasing ...
... at Harbor-UCLA Medical Center (LA BioMed) will honor Los Angeles ... founder and president of Kakkis EveryLife Foundation, as its "Spirit ... 6 at the Terranea Resort in Rancho Palos Verdes. ... for the excellence each represents in his chosen field," said ...
Cached Medicine News:Health News:Crisis in Aging: Disability and Alzheimer's: Lack of Caregivers Threatens South Florida Seniors' Ability to Stay Home 2Health News:Crisis in Aging: Disability and Alzheimer's: Lack of Caregivers Threatens South Florida Seniors' Ability to Stay Home 3Health News:Crisis in Aging: Disability and Alzheimer's: Lack of Caregivers Threatens South Florida Seniors' Ability to Stay Home 4Health News:Dr. Marc Katz, Leading Podiatric Surgeon Adds High Powered Color Ultrasound To Cryosurgery Procedures and Treatments 2Health News:PCPs are front line defense in diagnosing serious illness in patients with acute lower back pain 2Health News:Women who make poor shoe choices at risk for foot pain later in life 2Health News:UNC expert: Better decision support tools needed for prostate cancer screening choice 2Health News:LA BioMed to honor Emil D. Kakkis, M.D., Ph.D., and LA County Supervisor Don Knabe 2
... Sterile E*Kits® can be a valuable ... care; when the items necessary for a ... facility protocols and continuum of care are ... are packaged in sequence of use, allowing ...
... to dry trays to specialty vaginal & ... Health offers the widest offering in patient ... that are proven to be safe and ... surgical site infections. Cardinal Health Scrub Care ...
The applicator is designed for a smooth delivery of the solution for surgical procedures....
... The Anti-HTLV Mixed Titer Performance Panel ... from weak to strong positive for antibodies ... is intended for use by manufacturers and ... assays. Comprehensive data from all major test ...
Medicine Products: